Why the study?
Does the residual SYNTAX score predict clinical outcomes in patients undergoing percutaneous coronary intervention?
Does the residual SYNTAX score predict clinical outcomes in patients undergoing percutaneous coronary intervention?
The residual SYNTAX score is an independent predictor of adverse outcomes after PCI, and achieving a reasonable incomplete revascularization (rSS≤8) yields similar mortality and myocardial infarction rates as complete revascularization.
rSS may aid post-PCI risk stratification in observational data; leaves open whether targeting lower scores improves outcomes in randomized trials.
AIMS: This study aimed to assess the prognostic capacity of the residual SYNTAX score (rSS) in a large cohort of patients undergoing percutaneous coronary intervention (PCI) in clinical practice. METHODS AND RESULTS: Ten thousand three hundred and forty-four (10,344) consecutive patients were prospectively enrolled. Complete revascularisation (CR; rSS=0), reasonable incomplete revascularisation (RICR; 0<rSS≤8), and ICR (rSS>8) were achieved in 5,375 (51.9%), 3,401 (32.9%), and 1,568 (15.2%) patients, respectively. During two-year follow-up, ICR patients had the highest incidence of major adverse cardiovascular and cerebrovascular events (MACCE; 20.0% vs. 13.6% vs. 8.7%, respectively; p<0.001). There was no difference in the incidence of all-cause death (1.2% vs. 1.0%; p=0.45), cardiac death (0.6% vs. 0.5%; p=0.31), and myocardial infarction (2.2% vs. 1.6%; p=0.07) between RICR and CR patients, while the rate of repeat revascularisation was significantly higher in RICR patients (9.8% vs. 5.8%; p<0.001). After multivariate analysis, rSS was an independent predictor of two-year cardiac death, myocardial infarction, revascularisation, and MACCE (p<0.05). CONCLUSIONS: Despite an increase in revascularisation, RICR was associated with a similar mortality and myocardial infarction to CR patients. rSS is a prognostic indicator after PCI in daily practice, and may be used to determine a reasonable level of revascularisation.
No takes yet. Share an insight, caveat, or question.
Song et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: